BeiGene
North America, Massachusetts, United States, Cambridge
Description
BeiGene is a global oncology company.
Investor Profile
BeiGene has backed more than 7 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 14% of its total and boasts 1 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Seed, Series B rounds (top funding stages).
- Majority of deals are located in United States, China.
- Strong thematic focus on Biotechnology, Medical, Life Science.
Stage Focus
- Series A (43%)
- Seed (29%)
- Series B (14%)
- Post Ipo Equity (14%)
Country Focus
- United States (71%)
- China (29%)
'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
Industry Focus
- Biotechnology
- Medical
- Life Science
- Health Care
- Oncology
- Pharmaceutical
- Therapeutics
- Biopharma
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does BeiGene frequently co-invest with?
'/%3e%3cuse xlink:href='%23a' transform='rotate(144 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(216 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(288 450 300)'/%3e%3c/svg%3e)
What are some of recent deals done by BeiGene?
Find More Investors Like BeiGene
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides
